Article
Using Drosophila amyloid toxicity models to study Alzheimer's disease
22 Mar 2024
Abstract excerpt
Alzheimer's disease (AD) is the most prevalent form of dementia and is characterised by a progressive loss of neurons, which manifests as gradual memory decline, followed by cognitive loss. Despite the significant progress in identifying novel biomarkers and understanding the prodromal pathology and symptomatology, AD remains a significant unmet clinical need. Lecanemab and aducanumab, the only Food and Drug...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
